Eradication of Tuberculosis– Current Status and the Way Forward
DOI:
https://doi.org/10.37506/mlu.v20i4.1813Keywords:
TB, MDR TB, XDR TB, Tuberculosis, Multidrug Resistant Tuberculosis, Extremely Drug resistant tuberculosis, TB vaccine, TB eradication, Millennium Development Goals, MDGsAbstract
It is estimated that about 25% of humanity is infected with the bacterium Mycobacterium tuberculosis. That
is about 2 billion people. Several new vaccines will pass Phase I clinical trials in the next few years. This
paper briefly summarizes past and present challenges to developing a vaccine against tuberculosis as well as
treating tuberculosis. TB is a pathogen that infects more individuals globally than any other communicable
disease. TB is particularly devastating in poor developing countries, notably in Africa and Southeast Asia.
Despite the WHO’s efforts to overcome TB, Multi Drug Resistant (MDR) TB and Extremely Drug Resistant
(XDR) TB are huge challenges.
Downloads
Published
2020-11-18
Issue
Section
Articles
How to Cite
Eradication of Tuberculosis– Current Status and the Way Forward. (2020). Medico Legal Update, 20(4), 278-280. https://doi.org/10.37506/mlu.v20i4.1813